APA (7th ed.) Citation

Yang, X., Wu, Y., Xu, S., Li, H., Peng, C., Cui, X., . . . Du, Y. (2023). Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: Artificial intelligence-facilitated molecular docking for drug discovery. BMC Endocrine Disorders, 23(1), 1. https://doi.org/10.1186/s12902-023-01360-z

Chicago Style (17th ed.) Citation

Yang, Xue, et al. "Targeting the Inward Rectifier Potassium Channel 5.1 in Thyroid Cancer: Artificial Intelligence-facilitated Molecular Docking for Drug Discovery." BMC Endocrine Disorders 23, no. 1 (2023): 1. https://doi.org/10.1186/s12902-023-01360-z.

MLA (9th ed.) Citation

Yang, Xue, et al. "Targeting the Inward Rectifier Potassium Channel 5.1 in Thyroid Cancer: Artificial Intelligence-facilitated Molecular Docking for Drug Discovery." BMC Endocrine Disorders, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12902-023-01360-z.